09 Nov 2017 Governance

Leukaemia UK is the new name for the ‘Elimination of Leukaemia Fund’

Since November 2017 Leukaemia UK is the new name for the Elimination of Leukaemia Fund.

For the last four decades, Leukaemia UK has been making a difference to those living with blood cancer. We fund emotional support, pay for new hospital facilities, offer critical financial help and fund innovative research into better care and treatments for blood cancers.

We have used this, our 40th year, to review our work and achievements to develop a new strategy and vision for the future.

We want to increase our impact by supporting more families affected by blood cancer and by working with more hospitals around the UK.

Now feels like a good time to change our name from the Elimination of Leukaemia Fund to Leukaemia UK to reflect this ambition. We still hold tight to the founding principles of this charity which are:

  • to improve care and support for people living with blood cancer
  • to fund innovative research to find kinder, more effective ways of treating blood cancer

We have been fortunate to benefit from free consultancy from Frontera, a creative digital agency. The company has helped us develop a new name, logo and brand, at no cost to our supporters.

This new name encompasses our work as a leading blood cancer charity working for a blood cancer cure and improved care.  Our work will remain the same, covering all blood cancers and related disorders.

Our name change won’t affect our charity registration number, office address, bank details and company numbers. For those who donate to us through payroll giving, standing order or direct debit, you won’t need to change anything.

We remain completely reliant on voluntary donations to keep our charity and its important work running. Thank you for your generous support and for being part of our exciting journey.

Find out more about:

 

Related posts

A decade on: Dr Javier Redondo Muñoz continues to shape the future of Leukaemia research

18 May 2026

A decade on: Dr Javier Redondo Muñoz continues to shape the future of Leukaemia research

Ten years after joining the second cohort of Leukaemia UK’s John Goldman Fellowships (JGF), Dr Javier Redondo Muñoz is continuing to shape the future of leukaemia research. Now leading his own team in…

1 in 4 leukaemia patients in England experiences an avoidable delay in diagnosis

18 September 2025

1 in 4 leukaemia patients in England experiences an avoidable delay in diagnosis

A first of its kind study, commissioned by Leukaemia UK, has revealed that a quarter (26%) of leukaemia patients in England experience avoidable delays in their diagnosis, resulting in a…

Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

26 October 2021

Leukaemia UK announced as one of five charities for star-studded event Shall We Dance? with Dame Arlene Phillips and Anton Du Beke

Leukaemia UK is delighted to have been announced as one of five charities for whom the proceeds of a new star-studded dance event, Shall We Dance?, will go towards when it takes place next year.

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

20 October 2023

Emerging leaders accolade for former Leukaemia UK John Goldman Fellows

Former Leukaemia UK John Goldman Fellows, Dr Matthew Blunt, University of Southampton and Dr Konstantinos Tzelepis, University of Cambridge have been recognised as ‘Emerging Leaders in Leukaemia’ by the major…